- 询价
- 辰辉创聚生物®️
- 中国
- NBAB-194805
- 2026年05月21日
- ELISA
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Influenza B virus HA/Hemagglutinin Protein
- 形态：
liquid
- 保存条件：
见COA
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 应用范围：
ELISA
- 抗体英文名：
Anti-Influenza B virus HA/Hemagglutinin Antibody
- 抗体名：
抗Influenza B virus HA/Hemagglutinin抗体
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名：NebuSelect™ Anti-Influenza B virus HA/Hemagglutinin Antibody
别名：Hemagglutinin, Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, HA
货号：NBAB-194805
品牌：辰辉创聚生物®️
规格：100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-Influenza B virus HA/Hemagglutinin Antibody (CAT# NBAB-194805) is produced in mammalian expression systems and exhibits specificity for Influenza B virus HA/Hemagglutinin. This antibody is validated for ELISA.
| 产品属性
Product Category：Recombinant Antibody
Reactivity：Influenza B virus
Specificity：Influenza B virus HA/Hemagglutinin
Immunogen：Recombinant Influenza B virus HA/Hemagglutinin Protein
Isotype：Monoclonal Human IgG
Purification：Protein A & Protein G Affinity Purification
Buffer：0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate：Unconjugated
Applications：ELISA
Dilution：ELISA 1:2000～1:10000
Storage：This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
郑重声明：仅用于科学研究，不可用于诊断或治疗。
更多产品细节，请联系我司相关客服人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Genotyping Anti-Hepatitis B Virus Drug Resistance
Agents available or in development for the treatment of chronic hepatitis B virus (HBV) infection fall into two major groups: immunomodulators, such as interferon-α and therapeutic vaccines, and nucleoside/nucleotide analogs
Induction of Anti-Hepatitis B Virus Immune Responses Through DNA Immunization
Cellular and humoral immune responses to different hepatitis B virus (HBV) antigens are believed to play an essential role in the elimination of virus by the host. It is well established that the humoral immune response to HBV envelope
Designing Clinical Development Programs for Anti-Hepatitis B Virus Drugs
Hepatitis B virus (HBV) infection remains one of the leading infectious causes of chronic liver disease and death in the world (1 ,2 ). With the advent of universal HBV vaccination and with the availability of antiviral therapeutics, HBV
技术资料暂无技术资料 索取技术资料
